"Initiatives such as Make in India and PLI Scheme have significantly strengthened India’s position as an attractive destination for investment"

What strategic factors drove the decision to expand the Peenya facilit...

July 1, 2026 | Wednesday | Views
“The N-FIS market is no longer emerging; it’s aligning with where healthcare is headed”

As N-FIS adoption grows across clinical practice, how do you see the c...

July 1, 2026 | Wednesday | Views
“For MedTech to work at the last mile, innovation must move beyond hardware”

Digital health has moved from being an innovation initiative to becomi...

June 24, 2026 | Wednesday | Views
From Insight to Impact: Why AI in Pharma struggles to scale - and What must change

Across the pharmaceutical industry, AI adoption has accelerated rapidl...

June 23, 2026 | Tuesday | Views
“There should be a stronger framework for IP creation and protection in the pharmaceutical context”

With your core strength being injectables and complex formulations, ho...

June 18, 2026 | Thursday | Views
Injectable Aesthetics and Regulatory Certainty: What CDSCO’s clarification means for MedTech

India's aesthetics market has expanded in a regulatory grey zone for y...

June 15, 2026 | Monday | Views
Why clear AI policy is the new catalyst for Life Sciences R&D

Artificial intelligence (AI) is no longer a future possibility for the...

June 9, 2026 | Tuesday | Views
India’s next pharma leap depends on fixing last-mile drug safety

Consider a temperature-sensitive biologic moving from a manufacturing ...

June 8, 2026 | Monday | Views
India’s ageing transition demands a fundamental redesign of healthcare

India likes to tell itself a comforting story: that it is a young nati...

June 5, 2026 | Friday | Views
“Success of the microbiome therapeutics market will require a more sophisticated investment environment”

Since the company's inception in 2020, what has the journey been like?...

May 28, 2026 | Thursday | Views
Embedding privacy in India’s MedTech ecosystem

The medical devices sector in India is an essential and integral const...

June 1, 2026 | Monday | Views
“Indian companies that migrate quickly from high-volume generics to speciality pharmaceuticals will be successful in the coming decade”

Supriya Lifescience has built a strong presence in niche APIs. How did...

June 1, 2026 | Monday | Views
"We want to make mRNA technology affordable to our society"

What were the unique highlights and achievements at TIGS in 2025? Res...

June 1, 2026 | Monday | Views
Bridging India’s MedTech Gap: From Imports to Innovation

India’s MedTech sector has momentum, but to compete globally we ...

June 1, 2026 | Monday | Views
Tech, Talent and Trillions: What Will Power India’s Medical Device Ecosystem?

As healthcare delivery becomes increasingly technology-driven and pati...

May 26, 2026 | Tuesday | Views
CAR-T Therapy in India: Market challenges, opportunities and path to scalable manufacturing

India stands at a pivotal moment in the evolution of cell therapy. Onc...

May 15, 2026 | Friday | Views
Leading radiology providers in India embrace AI technology: Understanding the Shift

India reads the highest number of radiology studies every year than an...

May 7, 2026 | Thursday | Views

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy